|Home | About | Journals | Submit | Contact Us | Français|
Tau and MAP1B are the main members of neuronal microtubule-associated proteins (MAPs), the functions of which have remained obscure because of a putative functional redundancy (Harada, A., K. Oguchi, S. Okabe, J. Kuno, S. Terada, T. Ohshima, R. Sato-Yoshitake, Y. Takei, T. Noda, and N. Hirokawa. 1994. Nature. 369:488–491; Takei, Y., S. Kondo, A. Harada, S. Inomata, T. Noda, and N. Hirokawa. 1997. J. Cell Biol. 137:1615–1626). To unmask the role of these proteins, we generated double-knockout mice with disrupted tau and map1b genes and compared their phenotypes with those of single-knockout mice. In the analysis of mice with a genetic background of predominantly C57Bl/6J, a hypoplastic commissural axon tract and disorganized neuronal layering were observed in the brains of the tau+/+map1b−/− mice. These phenotypes are markedly more severe in tau−/−map1b−/− double mutants, indicating that tau and MAP1B act in a synergistic fashion. Primary cultures of hippocampal neurons from tau−/−map1b−/− mice showed inhibited axonal elongation. In these cells, a generation of new axons via bundling of microtubules at the neck of the growth cones appeared to be disturbed. Cultured cerebellar neurons from tau−/−map1b−/− mice showed delayed neuronal migration concomitant with suppressed neurite elongation. These findings indicate the cooperative functions of tau and MAP1B in vivo in axonal elongation and neuronal migration as regulators of microtubule organization.
In developing neurons projecting elongated axons over enormous distances, the cytoskeletal system in the cytoplasm, which is composed of longitudinally arranged neurofilaments and microtubules (MTs), acts as a dynamic scaffold. MTs tend to form fascicles in which various kinds of crossbridge structures have been observed (Hirokawa 1982; Hirokawa et al. 1985). Microtubule-associated proteins (MAPs), a group of filamentous proteins, have been demonstrated as components of these extensive crossbridge structures associated with MTs (Hirokawa et al. 1985, Hirokawa et al. 1988; Sato-Yoshitake et al. 1989). The microtubule-associated protein 1B (MAP1B, known also as MAP1.2, MAP1X or MAP5) and tau are the main members of neuronal MAPs (Cleveland et al. 1977; Bloom et al. 1985; Noble et al. 1989). Tau is localized abundantly in axons (Hirokawa 1994). MAP1B is evenly distributed in dendrites, cell bodies, and axons of developing nerve cells, although the localization of phosphorylated MAP1B, which is preferentially incorporated into MTs (DiTella et al. 1996), is axon dominant (Sato-Yoshitake et al. 1989; Black et al. 1994). Tau is a component of short crossbridge structures (~20 nm long) between MTs (Hirokawa et al. 1988), whereas MAP1B is a constituent of longer ones (Sato-Yoshitake et al. 1989).
Transfection analyses have revealed that tau induces elongation of processes of nonneuronal cells with the formation of MT bundles (Kanai et al. 1989; Chen et al. 1992). On the other hand, studies on the effects of tau inactivation using antisense approaches (Caceres and Kosik 1990; Caceres et al. 1991) or chromophore-assisted laser inactivation (CALI; Liu et al. 1999) have implicated it in the establishment of neuronal polarity, axon outgrowth, and process stability. However, another study revealed that microinjection of anti-tau antibodies into cultured neurons did not result in inhibition of axonal extension (Tint et al. 1998). In regard to MAP1B, depletion of casein kinase II, which catalyzes phosphorylation of MAP1B, blocked neuritogenesis (Ulloa et al. 1993), and attenuation of MAP1B expression by antisense oligonucleotide treatment resulted in inhibition of neurite extension in PC12 cells (Brugg et al. 1993); both suggest a role of MAP1B in neurite growth. A recent study has reported results conflicting with previous data in that axon formation in cerebellar macroneurons in culture is inhibited by treatment with a mixture of tau and MAP1B antisense oligonucleotides, but not by the single suppression by any one of the two (DiTella et al. 1996).
In parallel to these in vitro studies, efforts have also been made to elucidate the functions of MAPs in vivo by analyzing a series of knockout mice. Analysis of tau-knockout nerve cells revealed a decrease in the number of MTs in small-caliber axons, while they have extended axons indistinguishable from wild-type controls (Harada et al. 1994). Behavioral experiments of tau-deficient mice revealed muscle weakness and memory disturbance (Ikegami et al. 2000). MAP1B-deficient mice showed a delay in caliber expansion and myelination of optic nerves (Takei et al. 1997). Another group reported a more severe phenotype of MAP1B-mutant mice, namely, an early embryonic death of homozygotes at embryonic day 8 (E8) and partial postnatal lethality with brain anomalies in heterozygotes (Edelmann et al. 1996). Their data also suggest a neuronal function of MAP1B, although it is considered that the severity of the phenotypes reported by them was not a consequence of a simple loss of MAP1B function, but of a toxic effect of a truncated protein translated from the mutated gene or of other causes (Takei et al. 1997). On the other hand, a recent report showed the requirement of a MAP1B-like protein, Futsch/22C10, for neurite development in Drosophila (Hummel et al. 2000).
Taken collectively, these studies using knockout mice have not fully elucidated the function of tau and MAP1B in the developing mammalian nervous system, possibly because of the presence of some compensatory mechanisms in vivo. Even in vitro studies have reported conflicting results (e.g., results of studies using antisense approaches vs. microinjection of antibodies). Thus, despite considerable effort, the exact functions of tau and MAP1B in vivo have remained unclear.
Tau and MAP1B are similar not only in their effects on MT dynamics and organization in vitro (promoting tubulin assembly, binding and stabilizing MTs, and forming crossbridge structures between MTs; Hirokawa 1994), but also in their cellular localization in neurons. Both of them are strongly expressed in developing axons, especially in the distal part, and are colocalized with MTs in growth cones (Black et al. 1994, Black et al. 1996). Thus, we generated double-knockout mice with disrupted tau and map1b genes and compared their phenotypes with those of single-knockout mice, to examine if tau and MAP1B have redundant functions in vivo, and if so, to determine what the function of tau and MAP1B as a group is. Our findings are summarized as follows: (a) dysgenesis of the axon tract with an alteration of MT constitution in vivo and suppression of axonal elongation in cultured neurons from the mutant mice; (b) MT disorganization in growth cones, which provides us new insights into the mode of action of MAPs, where and how they function with respect to the organization of MTs in axonal elongation; and (c) delayed neuronal migration resulting in perturbed neuronal layer formation, shedding light on novel aspects of the function of tau and MAP1B.
A mice line with disrupted tau and map1b genes was generated by crossing a line of tau-deficient mice (Harada et al. 1994) with one of MAP1B-deficient mice (Takei et al. 1997). Analyzed mice had a C57Bl/6J (>93%) ×129/Sv (<7%) background. Although spontaneous agenesis of the corpus callosum has been reported in some inbred strains of mice, including the 129/ReJ and 129/J lines, the C57Bl/6J×129/Sv hybrid line does not exhibit a significant incidence of agenesis of the corpus callosum (Wahlsten 1989). The genotype of the mice was determined by PCR of genomic DNA as previously described (Harada et al. 1994; Takei et al. 1997).
Age-matched mice were anesthetized with ether and transcardially perfused with Bouin's solution. Brain tissues were dissected out, dehydrated through a graded alcohol series, cleared with xylene, and embedded in Paraplast (Oxford Labware). The tissues were serially sectioned (7 μm thick) and stained by the Bodian method, a silver stain procedure for visualizing nerve fibers (Bodian 1936), or the hematoxyline-eosin (HE) method. Samples were microphotographed using an Optiphoto-2 microscope (Nikon).
Mice were anesthetized and transcardially perfused with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer. Brain tissues were dissected out, fixed overnight, processed by the conventional method, and viewed under a JEOL 1200EX electron microscope at 100 kV. Matching areas of each tissue were examined and photographed, and then the areas of axons and the numbers of MTs were directly measured and counted, respectively, from prints. The number of MTs was then converted to the density of MTs by dividing the counts by each axonal area.
The hippocampi of E16.5 fetuses were dissected and cultured as described previously (Harada et al. 1994). The cells were plated at a density of 50,000 cells per 35-mm dish. The neurons were directly microphotographed by diaphoto phase-contrast microscopy (Nikon) or observed after immunostaining. The length and the number of neurites were measured from immunofluorescence micrographs of the cells stained with an anti-tubulin antibody, and for the growth cone area, with phalloidin.
The cerebelli of postnatal day 0.5 (P0.5) pups were dissected and cerebellar aggregates were generated as described previously (Kobayashi et al. 1995; Bix and Clark 1998). Dissociated cerebellar granule cells form aggregate spheres that adhere to the laminin substrate during the first hour of plating. Neuronal processes extend from the aggregates. After several hours, small bipolar granule cells migrate unidirectionally away from the cell clusters along these neurites, followed by translocation of cell bodies outside the aggregate margin. The neurons were directly photographed by diaphoto phase-contrast microscopy (Nikon) or observed after immunostaining.
Immunocytochemistry was performed using a standard method as described previously (Tanaka et al. 1992). Samples were observed using a laser scanning confocal microscope (model MRC-1000; Bio-Rad) or an axiovert microscope (Carl Zeiss). The following monoclonal antibodies were used as the primary antibodies: 1B9 (Sato-Yoshitake et al. 1989) for phosphorylated MAP1B, tau-1 (Boehringer Mannheim) for tau. Cy3-conjugated anti-mouse IgG (Amersham Life Science) were used as the secondary antibody. FITC-conjugated phalloidin (Sigma-Aldrich) was used for staining F-actin.
Tau+/−map1b+/− mice grew with no apparent abnormalities. Their brain sections at 6 mo of age were histologically indistinguishable from those of tau+/+map1b+/+ mice (data not shown). To generate tau−/−map1b−/− mice, we crossed male and female tau+/−map1b+/− mice and determined the genotypes of their pups. We found a predicted Mendelian distribution of genotypes when we examined pups at E16.5 and P0.5 (Table ; P > 0.9, as determined by chi-square for independence test). However, when we performed PCR of the tail genomes of 4-wk-old mice, the results deviated from the Mendelian distribution (Table ). Interestingly, a large percentage of the tau+/+ map1b−/− mice (~40% of the total) died before they reached 4 wk of age (Table ). This differed from results reported previously, where tau+/+map1b−/− mice did not exhibit any significant postnatal lethality (Takei et al. 1997). This discrepancy is probably attributable to the change in the genetic background of mice used. In our previous work, we used mice with a genetic background of C57Bl/6J×129/Sv hybrid (50%/50%), whereas in this research we used mice whose genetic background was predominantly C57Bl/6J (>93%), generated by repeated backcrosses with C57Bl/6J mice. All of the following data, including the reexamination of single-knockout mice, were collected using mice with this genetic background. A considerably high incidence of postnatal death was also seen in tau+/−map1b−/− (~40% of total) and tau−/− map1b−/− (~80% of total) mice (Table ). Malnutrition and dehydration may be the cause of postnatal death, since tau+/+map1b−/−, tau+/−map1b−/−, and tau−/− map1b−/− mice often showed a lack of milk in their stomach (Fig. 1). Adult tau+/+map1b−/− and tau−/− map1b−/− mice displayed a slight drooping of their upper eyelids (blepharoptosis-like symptom), which was previously reported in tau+/+map1b−/− mice (Takei et al. 1997).
The whole-brain weights (cerebrum + cerebellum) of tau+/+map1b+/+, tau−/−map1b+/+, tau+/+map1b −/−, and tau−/−map1b−/− mice were measured at P0.5 and 4 weeks of age. There is no significant difference in the whole-brain weights between tau+/+map1b+/+ and tau−/−map1b+/+ mice (Table II; P > 0.7 at P0.5 and P > 0.4 at 4 weeks of age, as determined by Scheffe's post-hoc test). The whole-brain weight of tau+/+map1b−/− mice was significantly smaller than that of tau+/+map1b+/+ mice (Table II; P < 0.05 at P0.5 and P < 0.001 at 4 wk of age, as determined by Scheffe's post-hoc test). Whereas there was no significant difference in the whole-brain weights between tau+/+map1b−/− and tau−/−map1b −/− mice at P0.5, a significant difference in the values between the mice was observed at 4 wk of age (Table ), indicating that the difference in whole-brain weight becomes apparent during postnatal development.
Histological analysis of the brain sections revealed abnormalities of the axon tract of the tau+/+map1b−/− and tau−/−map1b−/− mice (Fig. 2). Severe dysgenesis of the forebrain commissural fiber bundles, corpus callosum, anterior commissure, and hippocampal commissure, which connect the left and right cerebral hemispheres, was observed in the brains of the tau−/−map1b−/− mice (Fig. 2D, Fig. H, and Fig. L, long and short arrows). Brains of tau+/+ map1b−/− mice also exhibited a reduction in the size of these structures (Fig. 2 C, G, and K, long and short arrows). The severity of the commissure defects in tau−/− map1b−/− mice was significantly severer than those in tau+/+map1b−/− mice, which was clearly shown by a quantitative comparison of the cross-sectional area of the commissural fiber tract at the midsagittal plane (Table ). The size of commissural fiber tracts of tau−/− map1b+/+ mice did not differ from that of tau+/+ map1b+/+ mice (Fig. 2B, Fig. F, and Fig. J, and Table III; corpus callosum+hippocampal commissure, P > 0.8; anterior commissure, P > 0.9, as determined by Scheffe's post-hoc test).
Noncommissural axon tracts such as tracts in the striatum (Fig. 2 D, arrowheads), cerebellar white matter (linea alba; Fig. 2 P, arrows), and tracts of the spinal cord (data not shown), were also hypoplastic in tau−/−map1b−/− mice. In addition, the cavum septi pellucidi was enlarged in the tau−/−map1b+/+ and tau+/+map1b−/− mice at P0.5 (Fig. 2F and Fig. G, asterisks).
Defects in the neuronal layer structures were another striking abnormality in the brains of the tau+/+map1b −/− and tau−/−map1b−/− mice (Fig. 3). The hippocampal pyramidal cell layer in the brains of tau+/+map1b−/− mice showed a split in the CA1 region (Fig. 3C and Fig. G, arrows), which is also a characteristic feature of reeler and mDab1-deficient mice (Trommsdorff et al. 1999). Tissue sections from the tau−/−map1b−/− mice exhibited more drastic layering defects than those of tau+/+map1b−/− mice, distorted shape of hippocampus (Fig. 3D and Fig. L), loose association of pyramidal neurons throughout the pyramidal cell layer (Fig. 3D and Fig. H, arrows), and undulated pyramidal cell layer (Fig. 3 L, arrows).
We next analyzed the anterior commissures by electron microscopy to investigate in detail the axonal structures in the mutant brains (Fig. 4 and Table ). In two independent experiments (#1 and #2), the cross-sectional area of axons and the MT number per axon of tau−/−map1b−/− mice were greatly reduced (Fig. 4 D and Table ). The differences in these parameters between tau−/−map1b −/− mice and mice of other genotypes were statistically significant (Table ). The density of MTs (MT number per axonal area) was, however, not significantly changed (tau+/+map1b+/+, 101 ± 3 (223), tau−/−map1b−/−, 97 ± 2 (710); mean ± SEM (n)/μm2; P = 0.29 by Student's t test). These data show that axonal development was inhibited in association with altered MT constitutions in tau−/−map1b−/− mice.
To compare the neurite development of control and mutant mice, cultured hippocampal neurons were analyzed. This culture system enabled us to investigate the polar development of neurons maintained separately from glias (Dotti et al. 1988). Within 1 d after plating, majority of these neurons had several extended minor processes. Within another few days, they had a single growing axon, which continued to elongate (Fig. 5). We examined the expression of tau and MAP1B in these neurons from tau+/+ map1b+/+ (Fig. 6, A–D) and tau−/−map1b−/− (Fig. 6, E–H) mice by double-staining with FITC-conjugated phalloidin (Fig. 6A, Fig. C, Fig. E, and Fig. G), and also antibodies against tau (Fig. 6B and Fig. F) or phosphorylated MAP1B (Fig. 6D and Fig. H). In neurons from tau+/+map1b+/+ mice, both tau and phosphorylated MAP1B were localized in an axon-dominant fashion, as reported previously (Black et al. 1994, Black et al. 1996; Fig. 6B and Fig. D), whereas neurons from tau−/−map1b−/− mice exhibited no immunoreactivity to the antibodies used (Fig. 6F and Fig. H). These data imply the presence of tau and MAP1B in the neurons of tau+/+ map1b+/+ mice and their absence in those of tau−/− map1b−/− mice.
Next, to assess the effect of tau and map1b mutation on neuronal differentiation, we measured the fraction of neurons at stage 3 (stage of axonal elongation; Dotti et al. 1988). Although a significant difference in the percentage of neurons at stage 3 was observed between cultures from tau+/+map1b+/+ and tau−/−map1b−/− mice, a proportion of neurons from tau−/−map1b−/− mice are polarized (Table ), with a single axon-like process distinguishable from the minor processes (Fig. 5, arrows). Tau−/−map1b+/+ and tau+/+map1b−/− neurons did not significantly differ from tau+/+map1b+/+ neurons in the percentage of neurons at stage 3 (Table ; P > 0.9 and P > 0.2, respectively, determined by Scheffe's post-hoc test). We performed a morphometric analysis of the neurons at stage 3. The number of processes per cell was not altered between cells from the different genotypes (Table VI; P > 0.15, as determined by one-way ANOVA). The axonal length of neurons from tau−/−map1b−/− mice was the shortest among those from the four genotypes (Fig. 5 and Table ). A decrease in average axonal length of cells from tau+/+map1b−/− mice was shown, although this was not statistically significant (Fig. 5 and Table VI; P > 0.05, as determined by Scheffe's post-hoc test). The difference between neurons from tau+/+map1b−/− and tau−/−map1b−/− mice was statistically significant (Table ). As reported previously (Harada et al. 1994), there was no significant difference in the axonal length between cultures from tau+/+map1b+/+ and tau−/−map1b+/+ mice (Fig. 5 and Table VI; P > 0.9, as determined by Scheffe's post-hoc test). The extension of minor processes was also affected in neurons from tau+/+map1b−/− and tau−/−map1b−/− mice (Fig. 5 and Table ). Tau+/+ map1b−/− and tau−/−map1b−/− neurons differed significantly from tau+/+map1b+/+ neurons in the length of minor process (Table VI; P < 0.01 and P < 0.001, respectively, determined by Scheffe's post-hoc test). There was no significant difference between neurons from tau−/− map1b+/+ and tau+/+map1b+/+ mice (Table VI; P > 0.9, determined by Scheffe's post-hoc test). Tau+/+ map1b−/− and tau−/−map1b−/− neurons did not significantly differ in the length of minor processes (P > 0.7, determined by Scheffe's post-hoc test). Thus, we concluded that tau and MAP1B act cooperatively in axonal elongation, but not in minor process elongation, where the null mutation of tau gene has little effect.
To investigate the cytoskeletal organization of cultured cells, we double-stained neurons with an anti-tubulin antibody and phalloidin, because actin microfilaments and MTs are the major determinants of neuronal shape (Tanaka and Sabry 1995). Cultured neurons from tau−/− map1b−/− mice exhibited a striking feature in their growth-cone morphology as well. The growth cone situated at the tip of axon-like processes in neurons of tau−/− map1b−/− mice cultured for 3 d often exhibited an extended form (Fig. 7C and Fig. D). The difference in the areas of the growth cones between tau−/−map1b−/− mice and mice of other genotypes was statistically significant (Table ). Tau−/−map1b+/+ and tau+/+map1b−/− neurons did not significantly differ from tau+/+map1b+/+ neurons in the areas of the growth cones (P > 0.9 and P > 0.5, respectively, determined by Scheffe's post-hoc test).
In the neurons from tau+/+map1b+/+ mice, the MTs in the growth cones at the tip of developing axons tended to bundle together rather tightly around the central region in the growth cones (Fig. 7 B, arrow). The neurons from tau−/−map1b−/− mice, however, had a quite different MT organization, where the MTs were splayed into single MTs with a slight tendency toward bundling, especially in the peripheral region of the growth cones (Fig. 7 D, arrows). F-actin in the growth cones of tau−/−map1b−/− mice was localized mainly in the filopodia, and not in the central MT-rich domain (Fig. 7 C, arrows), which differed strikingly from the case in the neurons from tau+/+ map1b+/+ mice (Fig. 7 A). From these data, we concluded that a cytoskeletal disorganization, mainly of the MTs, and also of actin filaments, was related to the abnormal shape of the growth cones in the tau−/−map1b−/− mice.
Histological analyses of tau−/−map1b−/− brains suggested the presence of a migration defect in tau−/− map1b−/− neurons. To elucidate this by comparing migration of tau−/−map1b−/− neurons with that of tau+/+ map1b+/+ neurons, we examined the unidirectional in vitro migration of granule cells from cerebellar cell reaggregates on a laminin substrate (Bix and Clark 1998; Kobayashi et al. 1995). Cerebellar granule cells can be easily identified by their bipolar, spindle-shaped morphology with neurites. These neurites were positive for tau and MAP1B immunoreactivities as revealed by immunofluorescence (data not shown). There was a striking difference between the migration of tau+/+map1b+/+ (Fig. 8 A) and tau−/−map1b−/− (Fig. 8 B) neurons from reaggregate clusters. We measured the distance that each neuron migrated after 24 h for each genotype, and confirmed quantitatively that mutant cells migrated at shorter distances than wild-type cells (Fig. 8 C). There were significant differences in migration distances from the cluster margin after 24 h between neurons derived from tau+/+ map1b+/+ and tau−/−map1b−/− mice (P < 0.001 by the Mann-Whitney rank sum test). No significant difference was observed in the size of cell clusters between genotypes (tau+/+map1b+/+; 38.4 ± 1.4 (35), tau−/−map1b−/−; 35.9 ± 1.6 (33), mean ± SEM (number of aggregates examined) μm, P > 0.2, Student's t test). As neurites serve as the migration substrate for neurons, neurite lengths were compared between genotypes and a significant difference in the mean length of neurites were observed (Table ). We compared the migration index, defined as the ratio of the number of neurons that migrated over one-third of the neurite length to the total number of migrating neurons (Kobayashi et al. 1995), to evaluate whether the observed delay in migration of tau−/−map1b−/− neurons is dependent on the suppression of neurite elongation. No significant difference in mean migration index was observed between tau+/+map1b+/+ and tau−/−map1b−/− aggregates (Table VIII; P > 0.2 by Student's t test), suggesting that the inhibition of neuronal migration of tau−/− map1b−/− neurons was due to the suppression of neurite elongation.
A great deal of interest has been focused on the cytoskeletal basis of neuronal development. Although tau and MAP1B have been implicated in the process, the functions of tau and MAP1B in vivo remain controversial.
In the analysis of mice with a genetic background of predominantly C57Bl/6J (>93%), tau+/+map1b−/− mice have a partial postnatal lethality. A hypoplastic commissural axon tract and disorganized neuronal layering were observed in their brains, indicating the importance of MAP1B in axonal development and neuronal layer formation. These phenotypes are markedly more severe in the tau−/−map1b−/− double mutant, demonstrating the synergistic effects of tau and map1b mutations on neuronal morphogenesis.
In tau−/−map1b−/− mice, major commissural fibers such as the corpus callosum and anterior commissure were severely affected. Noncommissural long tracts in the cerebellum and the spinal cord were also hypoplastic. Electron microscopy revealed a decrease in the cross-sectional area of axons, which means that reduction in size of the axon tracts was mainly due to defective development of neuronal axons, and not of other cellular components such as glial cells. This assumption is supported by observations in the cultured hippocampal neurons, which indicate that defects in axon tract formation are cell-autonomous and can be satisfactory explained by inhibition of nerve growth.
In tau+/+map1b−/− and tau−/−map1b−/− cultures, minor process elongations were also affected. As no significant difference in the minor process length was observed between tau+/+map1b−/− and tau−/−map1b−/− cultures, the mutation of map1b gene is considered to be mainly responsible for this phenotype.
Growth cone translocation is a key event in axonal elongation. The sequence of cytoskeleton-dependent advance of the growth cone can be subdivided into the following four stages (Mitchison and Kirschner 1988; Tanaka and Sabry 1995). Stage of exploration (stage 1): during this stage, the filopodia and lamella in the growth cones are highly dynamic, and their shapes are mainly determined by the organization of actin microfilaments within them. MTs are localized in the central domain of the growth cone. Stage of MT invasion (stage 2): MTs invade into the periphery of the growth cone. Stage of stabilization (stage 3): MTs are organized to form a bundle in the growth cone. Stage of axon formation (stage 4): the plasma membrane of the growth cone collapses around the MT bundle to generate a new axon tube.
We found abnormalities in the shape and cytoskeletal organization of growth cones in tau−/−map1b−/− mice. Their MT-rich central domain was often extended, and the MTs were splayed into single MTs with little tendency toward bundle formation. These findings strongly indicate that stages 3 and 4 are selectively disturbed in the affected growth cones. In normally developing neurons, tau and MAP1B are colocalized with MTs in the growth cones (Black et al. 1994, Black et al. 1996), and are components of the filamentous structures that form crossbridges between the MTs (Hirokawa et al. 1988; Sato-Yoshitake et al. 1989). When transfected to non-neuronal cells, they induce reorganization of the MT network into bundle formation (Kanai et al. 1989; Chen et al. 1992) and reduce MT spacing (Tögel et al. 1998). Taken collectively, it is considered that the activity of these MAPs zips MTs at the neck of the advancing growth cones, and converts the dynamic MTs into highly organized parallel arrays of axonal MTs (Fig. 9). Our data also suggest that the coalescence of the plasma membrane cortex at stage 4 requires prior bundle formation of the MTs.
Another noteworthy finding of our study was the disruption of neuronal layer formation in vivo and a delayed neuronal migration in vitro. This suggests that tau and MAP1B are involved not only in axonal extension, but also in the motile behavior of migrating neurons as MT organizers.
In neuronal migration, a nuclear displacement within the leading process follows process formation. A coordinated organization of actin microfilaments and MTs is required in this process (Rivas and Hatten 1995; Rakic et al. 1996). Recently, LIS1 and Doublecortin (DCX) were shown to relate with MT organization in migrating neurons. DCX, a product of doublecortin gene that is responsible for X-linked lissencephaly, binds to and stabilizes MTs (Francis et al. 1999; Gleeson, et al. 1999), and LIS1, which is defective in cases with Miller-Dieker lissencephaly, reduces catastrophic events of MTs (Sapir et al. 1997). A Lis1 homologue in Aspergillus nidulans, nudF, affects nuclear migration by acting on the dynein motor system (Morris et al. 1998).
We observed a delay in neuronal migration with a concomitant suppression in leading process elongation in tau−/−map1b−/− reaggregate clusters, which suggests that tau and MAP1B act primarily on leading process elongation, not in nuclear displacement during neuronal migration.
Recent studies indicate that tau or MAP1B interacts with non-MT cellular components. Tau interacts with a neural plasma membrane through its projection domain (Brandt et al. 1995). MAP1B is associated with actin filaments (Tögel et al. 1998) and a membrane receptor GABA(C) (Hanley et al. 1999). We found an altered F-actin localization, as indicated by the absence of phalloidin staining in the central MT-rich domain, in mutant growth cones. We cannot conclude for certain whether this directly reflects the loss of tau and MAP1B functions, or is a secondary effect resulting from altered MT dynamics caused by the lack of MAPs. Further experiments will be required to characterize changes in actin filaments or plasma membrane dynamics in MAP-deficient neurons.
We thank S. Terada-Inomata, S. Nonaka, T. Nakata, N. Honma, H. Sato, N. Ono-uchi, M. Sugaya-Otsuka, and H. Fukuda (University of Tokyo) for their help.
This work was supported by a grant for Center of Excellence (COE) to N. Hirokawa.
Abbreviations used in this paper: E, embryonic day; HE, hematoxyline-eosin; MAPs, microtubule-associated proteins; MAP1B, microtubule-associated protein 1B; MTs, microtubules; P, postnatal day.